Sanjay (Hrsg.) Singh

Emerging Trends in Nanomedicine

Ebook (PDF Format)

This book illustrates the significance of nanotechnology in the delivery of anticancer and antimicrobial drugs, biomimetic technologies, tissue engineering, sensing, diagnostics, and artificial enzymes. It first briefly discusses the use of nanotechnology for the delivery of anticancer medications, and the concept and applications of catalytically active nanomaterial-based artificial enzymes for sensing and diagnostic applications. It then explores the use of silver nanoparticle-based novel antimicrobials, and comprehensively reviews the role of nanomaterials in developing biomedical implants and tissue engineering applications. Lastly, it of… Mehr

CHF 165.50

Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)

Versandfertig innerhalb 1-3 Werktagen
Versandkostenfrei

Produktdetails

ISBN: 978-981-1599-20-0
EAN: 9789811599200
Produktnummer: 36079349
Verlag: Springer
Sprache: Englisch
Erscheinungsjahr: 2021
Plattform: PDF
Masse: 5'857 KB

Über den Autor

Dr. Sanjay Singh is currently an Associate Professor at the Division of Biological and Life Sciences, Ahmedabad University, Gujarat, India. After completing his Ph.D. at CSIR-National Chemical Laboratory, Pune, India, he continued his research as a postdoctoral fellow at the University of Central Florida and the Pennsylvania State University, USA. His research interests include the synthesis of novel anti-cancer drug formulations and nanomaterials with biological, enzyme-like characteristics. He has received numerous national and international awards, such as an Endeavour Research Fellowship, YY Memorial Award (2016), International Association of Advanced Materials Scientists Medal (2017), Ambassador Australian Awards (2017), and an EMBO Fellowship.Dr Singh has published over 80 papers in international, peer-reviewed journals, and authored and co-authored several books and book chapters. He has also worked as a guest editor for various annual meetings of the Society for Redox Biology and Medicine (SfRBM) and the World Molecular Imaging Society (WMIS). He is the Associate Editor-in-Chief of 3Biotech (Springer Nature), OncoTargets, and Therapy.